Related Experiment Video

Updated: Aug 22, 2026

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods
10:40

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods

Published on: December 21, 2019

Inhibitors of 3C cysteine proteinases from Picornaviridae

Manjinder S Lall1, Rajendra P Jain, John C Vederas

  • 1Department of Chemistry, University of Alberta, Edmonton, Alberta, Canada T6G.

Current Topics in Medicinal Chemistry
|August 24, 2004
PubMed

Insights

Researchers developed novel inhibitors targeting 3C proteinase enzymes in Hepatitis A virus (HAV) and Human Rhinovirus (HRV). These compounds show promise for developing new therapies against picornaviral pathogens.

Area of Science:

  • Virology
  • Biochemistry
  • Medicinal Chemistry

Background:

  • Picornaviridae are a significant family of RNA viruses causing human and animal diseases.
  • Hepatitis A virus (HAV) and Human Rhinovirus (HRV) are key picornaviral pathogens.
  • The viral 3C proteinase is essential for viral replication and maturation.

Purpose of the Study:

  • To design and synthesize novel inhibitors for HAV and HRV 3C proteinases.
  • To identify potential lead compounds for antiviral drug development against picornaviral infections.

Main Methods:

  • Synthesis and testing of various chemical inhibitors targeting 3C proteinase.
  • Enzyme-kinetics, mass spectrometry, and NMR spectroscopy to study enzyme-inhibitor interactions.

Main Results:

  • Thiol-reactive groups (iodoacetamides, beta-lactones, Michael acceptors, ketones, pseudoxazolones) effectively inhibited HAV and HRV 3C proteinases.
  • Detailed mechanistic insights into enzyme-inhibitor interactions and reactivity were obtained.

Conclusions:

  • Novel inhibitors targeting picornaviral 3C proteinases were identified.
  • These findings provide a basis for developing new antiviral agents against HAV, HRV, and other picornaviral diseases.

More Related Videos

Identifying Caspases and their Motifs that Cleave Proteins During Influenza A Virus Infection08:16

Identifying Caspases and their Motifs that Cleave Proteins During Influenza A Virus Infection

Published on: July 21, 2022

The Importance of Correct Protein Concentration for Kinetics and Affinity Determination in Structure-function Analysis19:16

The Importance of Correct Protein Concentration for Kinetics and Affinity Determination in Structure-function Analysis

Published on: March 17, 2010

Related Concept Videos

Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...